ArticleJHEP reports : innovation in hepatology2024

Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection.

Harry L Janssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.